- Home
- TALO vs HROW Comparison
TALO vs HROW Comparison
Compare TALO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- HROW
- Stock Information
- Founded
- TALO 2011
- HROW 1998
- Country
- TALO United States
- HROW United States
- Employees
- TALO N/A
- HROW N/A
- Industry
- TALO Oil & Gas Production
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- HROW Health Care
- Exchange
- TALO Nasdaq
- HROW Nasdaq
- Market Cap
- TALO 1.7B
- HROW 1.4B
- IPO Year
- TALO N/A
- HROW N/A
- Fundamental
- Price
- TALO $9.76
- HROW $38.68
- Analyst Decision
- TALO Buy
- HROW Strong Buy
- Analyst Count
- TALO 6
- HROW 7
- Target Price
- TALO $14.50
- HROW $68.50
- AVG Volume (30 Days)
- TALO 1.5M
- HROW 848.3K
- Earning Date
- TALO 11-05-2025
- HROW 11-12-2025
- Dividend Yield
- TALO N/A
- HROW N/A
- EPS Growth
- TALO N/A
- HROW N/A
- EPS
- TALO N/A
- HROW N/A
- Revenue
- TALO $1,931,650,000.00
- HROW $227,661,000.00
- Revenue This Year
- TALO N/A
- HROW $43.92
- Revenue Next Year
- TALO N/A
- HROW $41.32
- P/E Ratio
- TALO N/A
- HROW N/A
- Revenue Growth
- TALO 10.70
- HROW 47.69
- 52 Week Low
- TALO $6.23
- HROW $20.85
- 52 Week High
- TALO $12.71
- HROW $55.75
- Technical
- Relative Strength Index (RSI)
- TALO 53.73
- HROW 43.27
- Support Level
- TALO $8.97
- HROW $38.32
- Resistance Level
- TALO $9.34
- HROW $42.31
- Average True Range (ATR)
- TALO 0.38
- HROW 2.44
- MACD
- TALO 0.00
- HROW -0.36
- Stochastic Oscillator
- TALO 56.51
- HROW 32.87
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.